Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 3284 entries
View as:

Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia

Phase: N/A Priority: Normal
NCT ID: NCT06338839 Org: User:
Start: 12/28/23 End: 06/25/24 Due: 06/25/25

A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT06419413 Org: User:
Start: 01/08/24 End: 10/08/26 Due: 10/08/27

A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06555822 Org: User:
Start: 08/15/24 End: 03/06/25 Due: 03/06/26

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00660907 Org: User:
Start: 03/31/08 End: 01/31/13 Due: 01/31/14

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00628251 Org: User:
Start: 07/30/08 End: 09/19/18 Due: 09/19/19

Evaluation of Histamine H3 Receptor Radioligand [11C]AZ12807110 and Histamine H3 Receptor Occupancy of AZD5213 After Oral Administration

Phase: N/A Priority: Normal
NCT ID: NCT01194986 Org: User:
Start: 11/30/10 End: 06/30/11 Due: 06/30/12

EU Secondary Data Post-Authorisation Safety Study of AZD1222

Phase: N/A Priority: Normal
NCT ID: NCT05126992 Org: User:
Start: 02/18/22 End: 01/24/24 Due: 01/24/25

A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00392925 Org: User:
Start: 10/31/06 End: 09/30/07 Due: 09/30/08

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05797168 Org: User:
Start: 06/05/23 End: 01/06/28 Due: 01/06/29

Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT02319044 Org: User:
Start: 04/15/15 End: 07/06/20 Due: 07/06/21

A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Phase: N/A Priority: Normal
NCT ID: NCT05110976 Org: User:
Start: 12/16/21 End: 08/02/23 Due: 08/02/24

Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01154634 Org: User:
Start: 05/31/10 End: 09/30/10 Due: 09/30/11

Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts

Phase: N/A Priority: Normal
NCT ID: NCT00523484 Org: User:
Start: 05/31/07 End: - Due: -

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00562458 Org: User:
Start: 12/31/06 End: - Due: -

Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01947946 Org: User:
Start: 11/30/13 End: 07/31/14 Due: 07/31/15

Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database

Phase: N/A Priority: Normal
NCT ID: NCT05136547 Org: User:
Start: 01/06/22 End: 05/16/22 Due: 05/16/23

Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT00241501 Org: User:
Start: 02/29/04 End: 04/30/05 Due: 04/30/06

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

Phase: N/A Priority: Normal
NCT ID: NCT04625725 Org: User:
Start: 11/21/20 End: 12/08/23 Due: 12/08/24

HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

Phase: N/A Priority: Normal
NCT ID: NCT05913440 Org: User:
Start: 05/30/23 End: 03/31/25 Due: 03/31/26

A Study of AZD8233 in Participants With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT04641299 Org: User:
Start: 10/28/20 End: 07/20/21 Due: 07/20/22

Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers

Phase: N/A Priority: Normal
NCT ID: NCT00691353 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver

Phase: N/A Priority: Normal
NCT ID: NCT00272727 Org: User:
Start: 02/28/06 End: 05/31/07 Due: 05/31/08

AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00918398 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT04504669 Org: User:
Start: 08/18/20 End: 10/07/24 Due: 10/07/25

HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia

Phase: N/A Priority: Normal
NCT ID: NCT05892926 Org: User:
Start: 05/30/23 End: 06/28/24 Due: 06/28/25